English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Guangxin plans new build of annual 1,200-ton famoxadone facilityqrcode

Jan. 5, 2021

Favorites Print
Forward
Jan. 5, 2021

China's Anhui Guangxin Agrochemical Co., Ltd is planning a newbuild of an annual 1,200-ton famoxadone plant, located within the company’s existing plant area at Caijiashan Fine Chemical Park, Xinhang Town, Guangde City, Xuancheng, Anhui Province. 


The project will be implemented in two phases – Phase 1 of 500 tons and Phase 2 of 700 tons.


This was reported in their draft environmental impact assessment report on the annual 1,200-ton famoxadone project published on December 30, for public comment.


Famoxadone is one of the high-value products being developed at home and abroad. It has high activity, a unique action mechanism without cross-resistance to existing fungicides, and is very preventive in applications with a low dose. The product can be mixed with a variety of fungicides, which will effectively alleviate the resistance of systemic fungicides. 


In China, a large number of efficacy trials have been conducted on the performance of famoxadone and mixtures, the results have revealed apparent efficacy in the control of watermelon anthracnose, grape black pox, downy mildew and pear scab, even at a lower dose, with minimal contamination to crops. It is a low-toxic, efficient and environment-friendly novel pesticide.


Source: AgroNews

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox